Brii Biosciences Limited Working Capital to Net Assets Ratio
Brii Biosciences Limited working capital to net assets ratio. Brii Biosciences Limited (7SS) has a Working Capital to Net Assets ratio of 83.1% as of December 2025. Working capital of €1.93 Billion (current assets of €1.96 Billion minus current liabilities of €32.31 Million) is measured against net assets of €2.32 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Brii Biosciences Limited to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Brii Biosciences Limited (2020–2025)
Working capital to net assets ratio of Brii Biosciences Limited from 2020 to 2025. This chart shows how Brii Biosciences Limited's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 83.1%, reflecting working capital of €1.93 Billion against net assets of €2.32 Billion EUR. See 7SS cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Brii Biosciences Limited Working Capital to Net Assets Ratio by Year (2020–2025)
Brii Biosciences Limited working capital to net assets ratio by year from 2020 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Brii Biosciences Limited from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Brii Biosciences Limited total assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 83.1% | €1.93 Billion | €2.32 Billion | €1.96 Billion | €32.31 Million | ▼ -6.6 pp |
| 2024 | 89.7% | €2.34 Billion | €2.61 Billion | €2.41 Billion | €77.42 Million | ▲ +3.2 pp |
| 2023 | 86.5% | €2.66 Billion | €3.07 Billion | €2.78 Billion | €125.87 Million | ▼ -3.7 pp |
| 2022 | 90.2% | €2.85 Billion | €3.16 Billion | €3.08 Billion | €229.11 Million | ▼ -4.4 pp |
| 2021 | 94.6% | €3.13 Billion | €3.31 Billion | €3.41 Billion | €280.71 Million | ▲ +124.3 pp |
| 2020 | -29.7% | €517.61 Million | €-1.74 Billion | €1.09 Billion | €575.24 Million | — |